STATE STREET CORP - AIM IMMUNOTECH INC ownership

AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 39 filers reported holding AIM IMMUNOTECH INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of AIM IMMUNOTECH INC
ValueSharesWeighting
Q3 2023$78,762
-32.1%
173,1030.0%0.00%
Q2 2023$115,979
+55.8%
173,1030.0%0.00%
Q1 2023$74,434
-31.1%
173,103
-50.0%
0.00%
Q4 2022$107,982
+6.9%
346,206
+100.0%
0.00%
Q3 2022$101,000
-25.2%
173,1030.0%0.00%
Q2 2022$135,000
-26.2%
173,1030.0%0.00%
Q1 2022$183,000
+23.6%
173,103
+7.9%
0.00%
Q4 2021$148,000
-54.3%
160,4130.0%0.00%
Q3 2021$324,000
-6.1%
160,4130.0%0.00%
Q2 2021$345,000160,4130.00%
Other shareholders
AIM IMMUNOTECH INC shareholders Q3 2023
NameSharesValueWeighting ↓
XTX MARKETS LLC 11,019$20,0000.04%
Virtu Financial LLC 103,807$186,0000.02%
ACT WEALTH MANAGEMENT, LLC 10,000$18,0000.01%
SeaCrest Wealth Management, LLC 48,873$87,0000.01%
Arkadios Wealth Advisors 20,000$35,0000.01%
Traynor Capital Management, Inc. 14,777$26,0000.01%
GSA CAPITAL PARTNERS LLP 17,047$31,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 111,000$199,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 20,200$36,0000.00%
Tower Research Capital LLC (TRC) 12,513$22,0000.00%
View complete list of AIM IMMUNOTECH INC shareholders